GULF DRUG COMPANY
Supplier Forensic Analysis · Scanned: 2026/07/26
Open this supplier in the workbench →These findings identify statistical unusualness and named data patterns for review. They do not establish wrongdoing and require source verification.
CIPC screening
ClearCompliance
N/A/100
Awards
4
Total Value
R 1,5B
Recent Awards
4 awards · Total: R 1 458 136 738,37
HP09-2026SD: SUPPLY AND DELIVERY OF SOLID DOSAGE FORMS TO THE DEPARTMENT OF HEALTH FOR THE PERIOD 01 MAY 2026 TO 30 APRIL 2029
Health and Welfare Sector Education and Training Authority
Ref: HP09-2026SDR 1 184 493 578,06
02 Apr 2026
HP02-2025AI: Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the period 1 October 2025 to 30 September 2028.
Health
Ref: HP02-2025AIR 263 143 978,94
21 Aug 2025
Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) to the Department of Health for the period 1 October 2023 to 30 September 2025
Health
Ref: HP02-2023AIR 7 727 181,37
15 Jun 2023
SUPPLY AND DELIVERY OF SEMI-SOLID DOSAGE FORMS AND POWDERS TO THE DEPARTMENT OF HEALTH FOR THE PERIOD 1 JULY 2023 TO 30 JUNE 2026
ERRATUM 1: PLEASE NOTE THAT THE SPECIAL REQUIREMENTS AND CONDITIONS OF CONTRACT (SRCC) AS PUBLISHED WITH THE BID PACK ON 17 JUNE 2022 FOR TENDER HP08-2023SSP IS BEING REPLACED WITH THIS ERRATUM.
Health
Ref: HP08-2023SSPR 2 772 000,00
13 Feb 2023
AI Analysis
Powered by GeminiAI Forensic Analysis
Get AI-generated audit narratives with key findings and recommended actions.
Paid access from R499/mo
or upgrade to Pro Subscription
Procurement context
Competitive concentration, procurement-intelligence context, province health, and restricted-supplier status are available to forensic subscribers.
Unlock forensic context →CIPC screening signalsClear
No contributing warning signals in the current evidence.
Unlock Full Analysis
Get access to all forensic flags, evidence details, and AI-generated audit narratives.
View Full Intelligence Report
Get complete award history, director network, and compliance analysis.
View Report →